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lutamate transporters belong to a family of Na⫹- and
K⫹-dependent transporters that are responsible for the
transport of glutamate and aspartate into cells from bacteria to
man (1–3). Several human isoforms have been cloned (excitatory
amino acid transporters; EAAT1–5), and are found in the
plasma membrane of neurons and兾or glia throughout the central
nervous system (4–7), and homologs are found in non-neuronal
tissues (8). In the central nervous system, these transporters
maintain low resting extracellular levels of glutamate兾aspartate,
thereby preventing the neurotoxic effects of high excitatory
neurotransmitter levels, and during synaptic neurotransmission,
they regulate the concentration of neurotransmitters at the
synapse, leading to the modulation of the response of the
postsynaptic cells (9–13).
The functional properties of the glutamate transporters have
been studied extensively (14 –20). These proteins function both
as glutamate transporters and as glutamate-gated chloride
channels. Structural studies of the glutamate transporters have
been limited to unraveling the secondary structure, and several
models have been proposed containing 6 –10 transmembrane
␣-helices (21–24). The tertiary and quaternary structures of
the glutamate transporters are unknown. Here, we have used
freeze-fracture electron microscopy (25, 26) to examine the
quaternary structure of the neuronal excitatory amino acid
transporter-3 (EAAT3) (4). Our approach takes advantage of
the ability of Xenopus laevis oocytes to express a large number
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of copies of functional integral membrane proteins in the
plasma membrane, where their structure and function may
be examined (27–33). We report that functional EAAT3 is a
pentamer in the oocyte plasma membrane and contains an
external domain that projects ⬇3 nm into the extracellular
space.
Experimental Procedures
Expression of EAAT3 in Xenopus Oocytes. Stage V–VI Xenopus

laevis oocytes were injected with 50 nl of water or cRNA for
human EAAT3 (1 g兾l) (4). Oocytes were maintained in
Barth’s medium at 18°C for 1–4 days until used in experiments.
For all oocytes, the electrophysiological assay preceded the
freeze-fracture studies.
Electrophysiological Assay of EAAT3. Electrophysiological recordings were carried out using the two-electrode voltage clamp
technique at 21 ⫾ 1°C (34). EAAT3 function in the plasma
membrane was assayed as the maximum carrier-mediated charge
(Qmax) moved in response to a series of transmembrane voltage
pulses (14, 31, 34). Whole-cell capacitance also was measured in
these cells to estimate the total plasma membrane surface area
(1 F兾cm2) (27–29).
Freeze-Fracture and Electron Microscopy. After Qmax measure-

ments, oocytes were immediately fixed in 3% glutaraldehyde in
0.2 M sodium cacodylate (pH 7.35), frozen by immersion in
liquid propane, and stored in a liquid nitrogen freezer (27).
Samples were fractured at ⫺105 or ⫺150°C in a JEOL RFD9010CR freeze etch fracture system at ⱕ10⫺8 Torr. The fractured faces were replicated with platinum-carbon (Pt-C) at 80°,
and the replica was stabilized with carbon at 90° (⫺150°C).
Replicas were cleaned in sodium hypochlorite, washed in water,
and placed directly on 400-mesh copper grids. Replicas were
examined in a Zeiss 10C transmission electron microscope at 80
or 100 kV. Tilted images were obtained by using a goniometer
stage.
Freeze-Fracture Data Analysis. Twenty replicas from 15 EAAT3-

expressing oocytes were examined for this study. Using these
replicas, ⬎500 negative images of plasma membrane fracture
faces were obtained at ⫻50,000 –⫻80,000. Similar to other
recombinant membrane proteins expressed in oocytes,
EAAT3 partitioned only to the protoplasmic (P) face of the
plasma membrane (27–33) and, therefore, our study focused
on the particles of the P fracture face. For EAAT3 particle
density determinations, particles were sampled from six replicas from five oocytes. Images of P fracture faces were
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Freeze-fracture electron microscopy was used to study the
structure of a human neuronal glutamate transporter (EAAT3).
EAAT3 was expressed in Xenopus laevis oocytes, and its function
was correlated with the total number of transporters in the
plasma membrane of the same cells. Function was assayed as the
maximum charge moved in response to a series of transmembrane voltage pulses. The number of transporters in the plasma
membrane was determined from the density of a distinct 10-nm
freeze-fracture particle, which appeared in the protoplasmic
face only after EAAT3 expression. The linear correlation between EAAT3 maximum carrier-mediated charge and the total
number of the 10-nm particles suggested that this particle
represented functional EAAT3 in the plasma membrane. The
cross-sectional area of EAAT3 in the plasma membrane (48 ⴞ 5
nm2) predicted 35 ⴞ 3 transmembrane ␣-helices in the transporter complex. This information along with secondary structure
models (6 –10 transmembrane ␣-helices) suggested an oligomeric state for EAAT3. EAAT3 particles were pentagonal in shape
in which five domains could be identified. They exhibited fivefold symmetry because they appeared as equilateral pentagons
and the angle at the vertices was 110°. Each domain appeared
to contribute to an extracellular mass that projects ⬇3 nm into
the extracellular space. Projections from all five domains taper
toward an axis passing through the center of the pentagon,
giving the transporter complex the appearance of a pentonbased pyramid. The pentameric structure of EAAT3 offers new
insights into its function as both a glutamate transporter and a
glutamate-gated chloride channel.

Fig. 1. P face freeze-fracture micrographs of the plasma membrane of a control and an EAAT3-expressing oocyte. (A) The P face of control oocytes contains
⬇200 –350 particles兾m2, with a mean diameter of ⬇7.5 nm (32). In the oocyte shown, the particle density was 275 ⫾ 20兾m2 (n ⫽ 4953). (B) In oocytes expressing
EAAT3, a new population of ⬇10-nm diameter particles appeared in the P face. In the oocyte shown, the total particle density increased to 546 ⫾ 35兾m2 (n ⫽
4186). EAAT3 Qmax was 3.5 nC in this cell. Some endogenous and EAAT3 particles are enclosed in circles. Cyt, cytoplasm; ES, extracellular space. Scale bar A and
B ⫽ 200 nm.

enlarged to a final magnification of ⫻150,000 and digitized.
Particle densities were determined by counting P face particles
from known areas of the membrane (IMAGE software, NIH).
For each oocyte, a minimum of 4,000 particles were counted
from a minimum of 5 m2 of plasma membrane. For construction of the frequency histograms, particle diameter was
measured directly from the negatives by using a comparator
(Nikon, Model 6c) at a final magnification of ⫻1,000,000. The
diameter measurements were plotted in a frequency histogram
with a bin size of 0.5 nm and were fitted to a multiple Gaussian
function (Fig. 2B) (32). All values are reported as mean ⫾ SE.
To study the structure of EAAT3 particles, the negatives were
examined by using a comparator at ⫻1,000,000. Regions of
interest were then photographically reproduced to yield ⬇1500
prints of EAAT3 particles. From this pool, ⬎10,000 EAAT3
particles were closely examined to ascertain the details of the
proposed structural model. The dimensions of EAAT3 reported
in Fig. 6 were obtained from ⬇200 particles viewed at high angles
(80–90°) and have been corrected for the thickness of the Pt-C
coat. The area of individual EAAT3 particles was determined
from digitized images by using NIH IMAGE. Fivefold symmetrization of the particle shown in Fig. 5 was performed with the
IMAGIC analysis program (Image Science, Berlin) (35). All other
images shown are unprocessed images of individual EAAT3
particles in the plasma membrane.
Platinum-Carbon Grain Size. To estimate the resolution of the

freeze-fracture images, the size of the Pt-C grain was determined
by using images of ice surfaces and hydrophobic fracture faces
obtained at a defocus value of 250 nm (first minimum of the
contrast transfer function at ⬇1.2 nm⫺1). The diameter of the
grain was 1.0 ⫾ 0.1 nm (n ⫽ 100), and the grain center-to-center
spacing was 1.2 ⫾ 0.2 nm (n ⫽ 217). This limits the structural
resolution of the replicas to ⬇2.5 nm (36). The center-to-center
spacing is in agreement with our previous estimate of the Pt-C
film thickness of 1.2 ⫾ 0.2 nm (32) and indicates that the replicas
consist of a monolayer of Pt-C grains, where each grain is
composed of 2–3 platinum atoms.
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Results
The plasma membrane of native Xenopus laevis oocytes is unique
among cells because it contains a low density of integral membrane proteins that appear as intramembrane particles in the P
face (200–350兾m2) (Fig. 1A). Expression of recombinant
plasma membrane proteins increases the density of the particles
in the P face (27–33). For example, in the EAAT3-expressing
oocyte of Fig. 1B, the total particle density increased to 546 ⫾
35兾m2 (n ⫽ 4186). After correction for background density, this
corresponds to an increase in particle density of ⬇230兾m2 and
represents particles induced by EAAT3 expression. In the
oocytes used in this study, the density of EAAT3 in the plasma
membrane ranged from 200 to 800兾m2. Using the total membrane surface area obtained from whole-cell capacitance measured in the same cells, the density was used to estimate the total
number of EAAT3 particles in the plasma membrane. In the
oocyte shown, the total plasma membrane area was estimated
from the capacitance (200 nF) to be ⬇20 ⫻ 106 m2 (using 1
F兾cm2). Therefore, there were ⬇4.6 ⫻ 109 EAAT3 particles in
the plasma membrane. In the oocytes studied, the total number
of EAAT3 particles ranged from 4.5 ⫻ 109 to 2.5 ⫻1010 per cell.
The number of particles induced by EAAT3 expression was
directly proportional to EAAT3 Qmax measured in the same
oocytes (Fig. 2A). Qmax represents the total amount of carriermediated charge movement, which results from conformational
changes of the transporter in response to transmembrane voltage
pulses (34, 37). It is directly proportional to the maximum rate
of glutamate transport and is related to the total number of
functional transporter molecules in the plasma membrane according to: Qmax ⫽ Nez␦, where N is the total number of EAAT3
particles in the plasma membrane, e is the elementary charge
(1.6 ⫻ 10⫺19 C), and z␦ is the effective valence of the transporter
corresponding to a given number of elementary charges (z)
moving across a given fraction (␦) of the membrane electric field
(14, 27, 34). In EAAT3-expressing oocytes, Qmax ranged from 3
to 15 nC. The plot of Qmax vs. the number of EAAT3 particles
in the same cells yielded a straight line and had a slope of 7 ⫻
Eskandari et al.

10⫺19 C (Fig. 2 A), corresponding to an effective valence of 4 ⫾
1 elementary charges per EAAT3 particle. Similar values have
been found for the Na⫹兾glucose and Na⫹兾iodide cotransporters
(27, 31).
Having established that the number of particles induced by
EAAT3 expression was correlated with the function of the
transporter (Qmax), we performed a size-analysis on the freezefracture particles of the P face of control and EAAT3-expressing
oocytes. In control oocytes, the great majority (⬇95%) of the P
face endogenous integral membrane proteins have a mean
diameter of ⬇7.5 nm (32). The P face of EAAT3-expressing
oocytes contained two particle populations (Fig. 2B): one with
a mean diameter of 7.5 ⫾ 0.4 nm and another with a mean
diameter of 10.0 ⫾ 0.3 nm (n ⫽ 518). The 7.5-nm particle
population represents the endogenous plasma membrane integral proteins, as this population also is found in control cells (32).
In the EAAT3-expressing oocyte of Fig. 2B, the relative frequency of this population (27% of total) predicted a ⬇3.7-fold
increase in particle density and was consistent with the measured
increase in the density of P face particles in the same cell
(⬇1150兾m2; ⬇3.7-fold higher than background) (32). The
10-nm particle appeared only after EAAT3 expression, and its
total number in the plasma membrane was proportional to
EAAT3 Qmax (Fig. 2 A).
The cross-sectional area of the freeze-fracture particles of
integral membrane proteins is proportional to the number of
membrane-spanning ␣-helices. The relationship was established
by an analysis of the freeze-fracture particles of proteins of
known structure (opsin, aquaporin-1, and a connexin), and it was
found that on average each transmembrane ␣-helix occupies 1.4
nm2 in the plane of the membrane (32). The cross-sectional area
of EAAT3 was calculated either from the diameter obtained
from the frequency histogram (Fig. 2B) (assuming circular
cross-sectional geometry), or it was directly measured in ⬇100
EAAT3 particles viewed at 80–90° (see Fig. 3). After correction
for Pt-C film thickness, both area estimates yielded similar
results (45 ⫾ 5 vs. 48 ⫾ 5 nm2; P ⬎ 0.05). Using 1.4 nm2兾␣-helix,
Eskandari et al.

the area corresponds to that of an integral membrane protein
complex containing 35 ⫾ 3 transmembrane ␣-helices (Fig. 2C).
We then examined the shape of individual EAAT3 particles in
more detail. EAAT3 particles uniformly exhibited a pentagonal
shape, in which five ‘‘domains’’ could be identified (arrowheads
in Figs. 3 and 5). In each particle, five sides of the pentagon
(6.9 ⫾ 0.3 nm; n ⫽ 185) and five angles at the vertices (110 ⫾ 5°;
n ⫽ 185) could be measured. A central feature was present in
many of the pentagonal EAAT3 particles (arrows in Fig. 3).
EAAT3 particles exhibited fivefold symmetry because (i) the
sides of the pentagon were equal in size (6.9 nm), (ii) the angle
formed by the sides at the vertices was 110°; consistent with that
expected for an equilateral pentagon (108°), and (iii) for particles
viewed at ⬇90° (see below), application of 72° rotational symmetry transformations to the particles along an axis passing
through the center of the pentagon and perpendicular to the
plane of the membrane produced identical views of the particles
(see Figs. 3 and 5).
The pentagonal geometry was exhibited by the majority of
EAAT3 particles. However, only a small fraction exhibited
fivefold symmetry. Because the surface of the oocyte plasma
membrane contains folds and microvilli (Fig. 1) (27), we reasoned that the replica is not flat and, thus, contains particles
viewed at different angles depending on the local curvature of
the plasma membrane. A goniometer stage was used to image
individual EAAT3 particles at different tilt angles with respect
to the incident electron beam. As the viewing angle of each
particle was changed, there was a dramatic change in its appearance (Fig. 4). This experiment suggested that lack of fivefold
symmetry in most of the particles was due to the orientation of
the EAAT3 particles with respect to the electron beam. In
addition, the loss of pentagonal appearance of the tilted particles
suggested that the central feature within the pentagonal geometry was elevated with respect to the pentagon vertices (see
below). Therefore, the absence of symmetry in most of the
particles resulted from the height of the central feature and the
wavy nature of the oocyte plasma membrane.
PNAS 兩 July 18, 2000 兩 vol. 97 兩 no. 15 兩 8643
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Fig. 2. Quantitative analysis of EAAT3 expression in the plasma membrane. (A) Functional expression of EAAT3 in the plasma membrane was ascertained by
measurement of the Qmax in response to step jumps in membrane voltage. In the same oocytes, the total number of EAAT3 particles in the plasma membrane
was estimated (see text). The straight line is a linear regression through the data points with a slope of 7 ⫻ 10⫺19 C兾EAAT3 particle. The effective valence per
EAAT3 particle was 4 ⫾ 1 elementary charges. In view of the pentameric structure (see text), the effective valence per monomer is ⬇0.8 elementary charge. (B)
Size frequency histogram of P face particles of EAAT3-expressing oocytes (n ⫽ 518). There were two particle populations: one had a mean diameter of 7.5 ⫾ 0.4
nm corresponding to endogenous membrane proteins (hatched region), and the second had a mean diameter of 10.0 ⫾ 0.3 nm and was present only in
EAAT3-expressing oocytes. (C) The cross-sectional area of EAAT3 allows an estimation of the total number of membrane-spanning ␣-helices in the transporter
complex. E, The area of opsin, connexin50 (Cx50) and aquaporin-1 (AQP1) (adapted from ref. 32). The solid straight line is a linear regression through the open
circles. The broken straight line is the same linear regression extrapolated beyond the known values. The cross-sectional area of EAAT3 predicted an integral
membrane protein complex composed of 35 ⫾ 3 transmembrane ␣-helices (F).

Fig. 3. EAAT3 is pentagonal in the plane of the plasma membrane. Fourteen representative EAAT3 particles are shown in the P face of the plasma membrane.
In many particles, five ‘‘domains’’ (arrowheads), and a central feature (arrows) were observed. Below each image, the pentagonal structure of the same particle
is emphasized by superimposing the outline of the EAAT3 complex, as well as the center-to-vertex connections within the pentagonal arrangement. The viewing
angle for each particle was estimated from the height and position of the central feature in the pentameric complex (see text). Angles are reported with respect
to the plane of the plasma membrane (considered to be the horizontal). (Scale bar ⫽ 10 nm.)

To estimate the height of the central feature of the EAAT3
particles (i.e., the distance it protrudes into the extracellular
space), pairs of tilted images (12–24°) of individual particles were
examined by using stereological methods (see Fig. 4) (38). By
measuring the parallax difference between the central feature
and one vertex of the pentagon in stereo pair images, the height
of the central feature was estimated to be ⬇3 nm (n ⫽ 20).
Knowledge of the height of the external domain, and the
realization that EAAT3 is a symmetrical pentagon in 90° projection, allowed us to estimate the viewing angle that could
account for the observed projections of particles for which no tilt
images were available (Fig. 3). Because of the projection of the
central feature into the extracellular space, as the viewing angle

approaches 90°, the fidelity of the pentagonal appearance of
EAAT3 particles increases. Therefore, the apparent difference
in the images of the particles results from the angle at which the
particles are viewed and is not due to heterogeneity in size or
shape of the transporter in the plasma membrane (Figs. 3–5).
Discussion
The combined electrophysiological and electron microscopic
studies indicated that functional EAAT3 appeared as a distinct
pentagonal 10-nm diameter particle in the plasma membrane of
oocytes. The pentagonal 10-nm particle represents functional
EAAT3 in the plasma membrane because (i) it was the only
particle population that appeared in the P face of the plasma

Fig. 4. Tilted EAAT3 particles. EAAT3 particles were tilted with respect to the incident electron beam. (A and B) The same particles at two different tilt angles
separated by 12°. The pentagonal appearance of the particle enclosed by the circles was lost after tilting. The straight line represents the tilt axis, and the curved
arrow represents the tilt direction. (Scale bar A and B ⫽ 20 nm.)
8644 兩 www.pnas.org
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Fig. 5. High-magnification images of EAAT3. Upper shows four EAAT3 particles viewed at different angles. Lower shows the corresponding interpretive model
of EAAT3 at the appropriate viewing angle of the particle. The first particle from the left is a fivefold symmetrized EAAT3 particle. This image was obtained by
applying five consecutive 72° rotational symmetry transformations about an axis passing through the central feature and perpendicular to the plane of the
membrane. The raw image of this symmetrized particle is shown in Fig. 3 (⬇90°). In the model, the plane of the lipid bilayer is shown for clarity (Lower), but it
is emphasized that for particles in the P face, the outer lipid leaflet is removed during freeze-fracture exposing the hydrophobic core of the membrane. (Scale
bar ⫽ 10 nm.)

Eskandari et al.

(Fig. 5 and 6). The transporter exhibits fivefold symmetry in 90°
projections of the particles; however, as the viewing angle
deviates significantly from normal, the pentagonal appearance is
obscured because of the prominent external mass.
Although particle deformation caused by freezing, fracturing,
and replication may lead to errors in the shape and estimated
height of the external domain, that the estimated dimension (⬇3
nm) is within the resolution of the replicas (⬇2.5 nm) suggests
that the images may be used to make predictions about the
tertiary structure of EAAT3. The EAAT3 external domain
inferred from the images is estimated to occupy ⬇50 nm3,
corresponding to a mass of ⬇40 kDa (using 0.73 cm3兾g). A large
extracellular loop predicted to connect transmembrane domains
3 and 4 may contribute to this extracellular mass (1–6). It
contains ⬇94 amino acids, leading to a mass of ⬇12 kDa (4), and

NEUROBIOLOGY

membrane after EAAT3 expression; (ii) its total number in the
plasma membrane was directly correlated with EAAT3 Qmax
measured in the same cells; (iii) control oocytes exhibited neither
charge movement (Q) as that seen in EAAT3-expressing cells,
nor a pentagonal 10-nm particle population in the plasma
membrane; and (iv) expression of a wide variety of other
recombinant membrane proteins does not give rise to pentagonal
10-nm particles, as each recombinant protein leads to the
appearance of a distinct particle with a unique size and shape;
examples include aquaporin-0 (tetramer), aquaporin-1 (tetramer), connexin50 (hexamer), opsin (monomer), epithelial Na⫹
channel (octamer), cystic fibrosis transmembrane conductance
regulator (dimer), and Na⫹兾glucose cotransporter (monomer)
(29, 32, 33).
The cross-sectional area of integral membrane proteins can be
estimated from the area of their freeze-fracture particles, and it
can be used to estimate the number of membrane-spanning
␣-helices (32). The EAAT3 cross-sectional area was 48 ⫾ 5 nm2,
corresponding to 35 ⫾ 3 transmembrane ␣-helices (using 1.4
nm2兾helix). Topological models of the glutamate transporters
predict 6–10 transmembrane ␣-helices (21–24). Despite uncertainties about the secondary structure, the large protein complex
seen in the freeze-fracture images is suggestive of an oligomeric
state for EAAT3, where 3–6 subunits are present in the transporter complex.
High-magnification freeze-fracture images further supported
the oligomeric structure and, in addition, showed EAAT3 to be
a symmetrical pentamer in the plasma membrane. The EAAT3
particle is characterized by five domains (subunits?) (Fig. 6).
Each domain projects ⬇3 nm into the extracellular space and
tapers toward an axis passing through the center of the pentameric complex. The tapered projections from all five domains give
rise to the observed central feature. The entire complex rising
out of the plane of the plasma membrane and reaching into
the extracellular space resembles a penton-based pyramid

Fig. 6. Dimensions of the neuronal glutamate transporter (EAAT3). The top
and side views of the EAAT3 pentameric complex are shown. All reported
values correspond to actual dimensions and were derived after correction for
the thickness of the platinum-carbon coat. The dashed line in the side view
indicates the position of the plane of the plasma membrane.
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the combined mass from five subunits would be ⬇60 kDa.
N-linked glycosylation at two potential sites may lead to an
additional mass of 5–10 kDa (39). Thus, this loop may account
for the external domain seen in the images. Whether this external
mass is involved in ligand recognition and binding remains to be
determined.
In view of the pentameric structure of the glutamate transporter, two questions need to be considered. First, does EAAT3
function as a pentamer? Second, is the oligomeric assembly
required for secondary active transport? The first question can
be addressed because images of the pentameric complex were
collected from the very oocytes in which EAAT3 functional
measurements were obtained. Results from radiation inactivation studies also suggest that the neuronal (EAAT1–3) and the
intestinal glutamate transporters function as oligomeric assemblies (40, 41). Furthermore, recent functional studies of EAAT3
in oocytes coexpressing various ratios of wild-type and cysteine
mutants (sensitive to methanethiosulfonate reagents) indicate
and this transporter is a functional oligomer (J. M. Hubbard and
M.P.K., unpublished data). Altogether, the data are suggestive
of EAAT3 as a functional oligomer in the plasma membrane,
where it is most likely composed of five identical subunits.
The second question involves the functional unit of EAAT3.
Is the functional unit the pentameric complex, or is each EAAT3
monomer sufficient to perform secondary active transport? This
question is more difficult to address based on the data obtained
here; however, evidence from other ion-driven transporters
indicates that oligomeric assembly per se is not necessary for

secondary active transport. The mammalian Na⫹兾glucose cotransporter and Escherichia coli lactose permease both function
as monomeric units (32, 42). What then is the significance of the
pentameric assembly in the neuronal glutamate transporter? It
has been shown that in addition to their function as secondary
active transporters of glutamate, these proteins behave as glutamate-activated chloride channels (5). Chloride flux through
the channel is not thermodynamically coupled to glutamate
transport (1, 2). It is possible that the EAAT3 monomer can
perform secondary active transport, but the chloride channel
mode seen in these transporters is a consequence of the oligomeric assembly. In many multimeric ion channels, the subunits
surround and contribute to the lining of the ion permeation
pathway. This also may be the case for the EAAT3 chloride
channel.
In summary, using freeze-fracture electron microscopy, we have
shown that EAAT3 exists as a functional pentamer in the plasma
membrane. The transporter complex resembles a penton-based
pyramid that projects ⬇3 nm into the extracellular space. The
oligomeric structure of EAAT3 may be responsible for its dual
function as a secondary active transporter and an ion channel.
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M., Lehre, K. P. & Danbolt, N. C. (1996) J. Biol. Chem. 271, 27715–27722.
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